Exit Text Mode

Macular Disease Foundation Australia logo

    Research news

    Research News

    The latest funding round now brings MDFA’s commitment to macular disease research to $5.8 million across 35 projects since 2011.

    Read more

    Most recent

    Excellence in Research Award in honour of Richard Grills (AM)

    Composition and functionality of high-density lipoprotein in age-related macular degeneration and a high-risk disease phenotype

    2023 Research Grant Family Fund recipient

    Redefining macular disease diagnosis to improve access to emerging therapies

    2023 Research Grant Recipient

    Investigating mitochondrial dysfunction in macular degeneration – towards new treatments and biomarkers

    2023 Research Grant Family Fund recipient

    Evaluating the potential of hyperspectral imaging for detecting and monitoring geographic atrophy Accurate monitoring of

    Vabysmo® (faricimab) now available in Australia 

    Vabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia

    Faricimab one step closer

    Faricimab has taken one step closer towards clinics in Australia.

    Image of an Indian man in blue shirt

    Macular disease research highlights

    The latest research relevant to optometrists and other health professionals

    Loading...